Skip to content
A1619Assembly2023-2024 SessionSame asS1001

Stop Delays for HIV Drugs

Official title

“Prohibits insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs prescribed to a person for HIV or AIDS”

Sponsor Linda RosenthalAD-67+3 co-sponsorsAffects Finance
Status
Assembly Floor Calendar
Impact
7/10
Significant
Outcome
Companion signed

Bill progress

Signed via S1001

What's happening

This bill prohibits insurance policies from requiring prior authorization for antiretroviral drugs used to treat or prevent HIV/AIDS.

Why it matters

  1. Eases access to critical HIV/AIDS medications. By removing prior authorization requirements, patients can get prescribed antiretroviral drugs without insurance-related delays that could interrupt treatment or prevention, which is vital for managing HIV effectively and preventing its spread.

  2. Reduces administrative burden on healthcare providers. Doctors and clinics no longer need to go through time-consuming paperwork or phone calls to justify antiretroviral prescriptions, freeing up resources for direct patient care.

  3. Supports public health goals. Easier access to antiretroviral drugs can help reduce new HIV infections and improve health outcomes for people living with HIV/AIDS, aligning with broader efforts to control and eventually end the HIV epidemic.

  4. Promotes equity in healthcare. Prior authorization processes can disproportionately impact marginalized or vulnerable populations; eliminating these barriers helps ensure that everyone, regardless of background, can access life-saving HIV/AIDS medications without unnecessary obstacles.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Stop Delays for HIV Drugs

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Linda Rosenthal

Assembly Member · Assembly District 67

History

  1. Substituted by S1001A
  2. Rules report cal.301
  3. Reported
  4. Reported referred to rules
  5. Reported referred to ways and means
  6. Print number 1619a
  7. Amend (t) and recommit to insurance
  8. Referred to insurance
  9. Referred to insurance

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S1001Senate

No Delays for HIV Drugs

Signed by Governor · Sponsor Brad Hoylman-Sigal

Impact 7 · SignificantSigned into law

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

1619--A

2023-2024 Regular Sessions

IN ASSEMBLY

January 17, 2023

Introduced by M. of A. L. ROSENTHAL, SIMON, BRONSON -- read once and referred to the Committee on Insurance -- recommitted to the Committee on Insurance in accordance with Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the insurance law, in relation to prohibiting insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs to certain persons

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 39 to read as follows:

(39) No policy that provides coverage for antiretroviral prescription drugs prescribed for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) shall subject such drugs to prior authorization.

§ 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 22 to read as follows:

(22) Every group or blanket policy delivered or issued for delivery in this state that provides coverage for antiretroviral prescription drugs for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) shall not subject such drug to a prior authorization requirement.

§ 3. Section 4303 of the insurance law is amended by adding a new subsection (vv) to read as follows:

(vv) Any contract issued by a medical expense indemnity corporation, a hospital service corporation or a health services corporation that provides coverage for antiretroviral prescription drugs for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) shall not subject such drug to a prior authorization requirement.

§ 4. This act shall take effect on the one hundred eightieth day after it shall have become a law.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD04099-02-4

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.